Oncolytics Biotech (ONCY) Submits Orphan Drug Designation App to U.S. FDA for REOLYSIN
Tweet Send to a Friend
Oncolytics Biotech (Nasdaq: ONCY) announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE